Clinical trial
Total and Ionized Magnesium Kinetics During Citrate-Anticoagulated Continuous Renal Replacement Therapy
NCT07906340 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Total and Ionized Magnesium Kinetics During Citrate-Anticoagulated Continuous Renal Replacement Therapy
- Lead sponsor
- Region Skane
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- January 31, 2028
- Enrollment
- 35 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
continuous renal replacement therapy (crrt), magnesium
Primary endpoints
Registered primary outcome measures; 5 primary.
-
Changes in systemic total magnesium concentration
Changes in systemic total magnesium concentration (mmol/L), measured using conventional clinical laboratory methods, will be assessed from baseline and over time during continuous renal replacement therapy with regional citrate anticoagulation.
-
Changes in systemic ionized magnesium concentration
Changes in systemic ionized magnesium concentration (mmol/L), measured using ion-selective electrode technology, will be assessed from baseline and over time during continuous renal replacement therapy with regional citrate anticoagulation.
-
Citrate-associated changes in magnesium ionization
Changes in the ionized magnesium fraction (ionized magnesium/total magnesium) between systemic and pre-filter blood will be assessed following administration of citrate-containing predilution fluid, accounting for dilution. Ionized magnesium will be measured using ion-selective electrode technology and total magnesium using conventional clinical laboratory methods.
-
Magnesium flux across the extracorporeal filter
Magnesium flux across the extracorporeal filter (mmol/h) will be calculated using total and ionized magnesium concentrations in pre-filter and post-filter blood and effluent fluid, accounting for blood flow rates, treatment fluid flow rates and fluid composition. Ionized magnesium will be measured using ion-selective electrode technology and total magnesium using conventional clinical laboratory methods.
-
Net magnesium loss attributable to CRRT
Net magnesium loss attributable to CRRT (mmol/h) will be calculated from magnesium removal in the effluent, accounting for magnesium supplied through dialysate and post-filter replacement fluids. Calculations will use the actual treatment fluid composition and flow rates at each sampling time. Ionized magnesium will be measured using ion-selective electrode technology and total magnesium using conventional clinical laboratory methods.
Lead sponsor's other trials
Region Skane, most recent start first.
+379 more trials See the organization page